Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TECLISTAMAB for Primary amyloidosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where TECLISTAMAB was used for Primary amyloidosis.

Most Reported Side Effects for TECLISTAMAB

Side Effect Reports % Deaths Hosp.
Cytokine release syndrome 257 21.1% 37 98
Pneumonia 101 8.3% 39 83
Plasma cell myeloma 100 8.2% 51 22
Immune effector cell-associated neurotoxicity syndrome 99 8.1% 34 45
Pyrexia 86 7.0% 25 52
Covid-19 82 6.7% 21 32
Infection 58 4.8% 17 20
Drug ineffective 52 4.3% 11 12
Neutropenia 48 3.9% 7 15
Sepsis 48 3.9% 36 41
Febrile neutropenia 44 3.6% 5 38
Death 34 2.8% 34 5
Off label use 34 2.8% 11 11
Covid-19 pneumonia 31 2.5% 6 31
Diarrhoea 28 2.3% 4 11

Other Indications for TECLISTAMAB

Plasma cell myeloma (736) Product used for unknown indication (251) Plasma cell myeloma refractory (205)

Other Drugs Used for Primary amyloidosis

BORTEZOMIB (905) DEXAMETHASONE (744) DARATUMUMAB (609) CYCLOPHOSPHAMIDE (580) LENALIDOMIDE (233) MELPHALAN (163) POMALIDOMIDE (126) VENETOCLAX (47) DARATUMUMAB\HYALURONIDASE-FIHJ (44) IXAZOMIB (40)

Related Pages

TECLISTAMAB Full Profile All Primary amyloidosis Drugs TECLISTAMAB Demographics TECLISTAMAB Timeline